The Complex Role of Triglycerides in Cardiovascular Disease
The DOI matches its Crossref record.
Abstract
The objectives of the present work were to obtain a summary estimate of the magnitude of association between triglycerides and cardiovascular disease in the general population based on currently available data. Our goal was to determine whether this relationship is independent of other risk factors, particularly high density lipoprotein cholesterol (HDL-C), using semi-quantitative meta-analysis. We only included studies reporting the association between fasting triglyceride levels and incident cardiovascular disease endpoints. Twenty-one studies including 65,863 men and 11,089 women were selected for the analysis from population-based prospective studies using standard meta-analysis calculations, relative risks (RR) and 95% confidence intervals (CI). Multivariable adjusted RRs were determined only for the studies reporting adjustment for HDL-C (9 studies in men, 2 studies in women). These analyses indicate plasma triglycerides are an independent predictor of cardiovascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, attention has focused on non-fasting triglycerides, which may be more strongly related to risk independently of the effects of HDL cholesterol.53 -55”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [54]
Citations
Cites
Still being checked.
Cited by
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 691
Fat Depots, Free Fatty Acids, and Dyslipidemia
Ebbert, J., & Jensen, M. (2013) · Nutrients · doi:10.3390/nu5020498 · Cited by 349
Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 311
Skulas-Ray, A. C., Kris-Etherton, P. M., Harris, W. S., Vanden Heuvel, J. P., Wagner, P. R., & West, S. G. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.003871 · Cited by 280
Franssen, R., Monajemi, H., Stroes, E. S. G., & Kastelein, J. J. P. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.003 · Cited by 270
Liu, J., Zeng, F.-F., Liu, Z.-M., Zhang, C.-X., Ling, W.-H., & Chen, Y.-M. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-159 · Cited by 192
Triglycerides as vascular risk factors: new epidemiologic insights.
Kannel, W. B., & Vasan, R. S. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832c1284 · Cited by 149
Hypertriglyceridemia and cardiovascular risk reduction
Jacobson, T. A., Miller, M. J., & Schaefer, E. J. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.05.002 · Cited by 164
Ridker, P. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097907 · Cited by 114
“... for other covariates—in particular HDL-C—markedly decreases both the magnitude and significance of observed epidemiologiceffects(1).Theextenttowhichinvestigatorshave sought to avoid nonfasting triglycerides as a method for risk detection is evident in a recent metaanalysis that limited evaluation only to those epi…”
Carmena, R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.04.027 · Cited by 105
Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia
Skulas-Ray, A. C., West, S. G., Davidson, M. H., & Kris-Etherton, P. M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1237 · Cited by 91
The independent relationship between triglycerides and coronary heart disease
Morrison, A. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4311 · Cited by 86
Effects of Modifying Triglycerides and Triglyceride-rich Lipoproteins on Cardiovascular Outcomes
Abdel-Maksoud, M. F., Sazonov, V., Gutkin, S. W., & Hokanson, J. E. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318165e2e7 · Cited by 57
Self-citationTarget Populations for Novel Triglyceride-Lowering Therapies
Nordestgaard, A. T., Tybjærg-Hansen, A., Mansbach, H., Kersten, S., Nordestgaard, B. G., & Rosenson, R. S. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.02.035 · Cited by 54
Hypertriglyceridemia and risk of coronary heart disease
Hokanson, J. E. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0112-7 · Cited by 53
Self-citationFranssen, R., Monajemi, H., Stroes, E. S. G., & Kastelein, J. J. P. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.003 · Cited by 64
Li, R., Zhang, Y., Zhu, W., Ding, C., Dai, W., Su, X., Dai, W., Xiao, J., Xing, Z., & Huang, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-73983-4 · Cited by 60
Jones, P. H., Bays, H. E., Davidson, M. H., Kelly, M. T., Buttler, S. M., Setze, C. M., Sleep, D. J., & Stolzenbach, J. C. (2008) · Clinical Drug Investigation · doi:10.2165/00044011-200828100-00003 · Cited by 37
Abdel-Maksoud, M. F., Eckel, R. H., Hamman, R. F., & Hokanson, J. E. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.02.011 · Cited by 40
Self-citationBrunton, S., & Collins, N. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x188017 · Cited by 33
Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects
Mijares, A. H., Ascaso, J. F., Blasco, M., Brea, Á., Díaz, Á., Mantilla, T., Pedro‐Botet, J., Pintó, X., & Millán, J. (2019) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2019.02.002 · Cited by 37
The ESC Textbook of Preventive Cardiology
Nixdorff, U., Achenbach, S., Bengel, F., Faggiano, P., Fernández, S., Heiß, C., Mengden, T., Mureddu, F., Nagel, E. C., Püntmann, V. O., et al. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199656653.001.0001 · Cited by 31
Sundvall, J., Laatikainen, T. K., Hakala, S., Leiviskä, J., & Alfthan, G. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.07.015 · Cited by 25
Egeland, G. M., Igland, J., Sulo, G., Nygard, O. K., Ebbing, M., & Tell, G. S. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314535681 · Cited by 25
Park, M., Seung, K., Kim, P.-J., Park, H., Yoon, S.-G., Baek, J.-Y., Koh, Y., Jung, H.-O., Chang, K., Kim, H.-Y., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.052 · Cited by 24
Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis
Li, Y., Li, C., & Gao, J. (2016) · Meta Gene · doi:10.1016/j.mgene.2016.04.004 · Cited by 20
Dishy, V., Liu, F., Ebel, D. L., Atiee, G. J., Royalty, J. E., Reilley, S. F., Paolini, J. F., Wagner, J. A., & Lai, E. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009332246 · Cited by 17
A Review on Metaanalysis of Biomarkers: Promises and Pitfalls
Lewington, S., Bragg, F., & Clarke, R. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.184226 · Cited by 22
The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic review.
Leonards, C. O., Ebinger, M., Batluk, J., Malzahn, U., Heuschmann, P. U., & Endres, M. (2010) · PubMed Central · doi:10.3389/fneur.2010.000133 · Cited by 15
Gentles, D., Metcalf, P., Dyall, L., Scragg, R. K. R., Sundborn, G., Schaaf, D., Black, P., & Jackson, R. T. (2007) · PubMed · Cited by 16
Riesgo cardiovascular residual de origen lipídico. Componentes y aspectos fisiopatológicos
Hernández‐Mijares, A., Ascaso, J. F., Blasco, M., Brea, Á., Rodríguez, Á. D., Mantilla, T., Pedro‐Botet, J., Pintó, X., & Millán, J. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.06.007 · Cited by 17
Maciejewski, S. R., & Hilleman, D. E. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.5.570 · Cited by 12
Roberts, J. L., He, B., Erickson, A., & Moreau, R. F. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.12.001 · Cited by 15
The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic review
Leonards, C. O. (2010) · Frontiers in Neurology · doi:10.3389/fneur.2010.00133 · Cited by 16
Diabetic dyslipidemia and the metabolic syndrome
Cefalu, W. T. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.04.001 · Cited by 20
Alternative hormone replacement regimens: is there a need for further clinical trials?
Welty, F. K. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200312000-00006 · Cited by 11
Rivera‐Paredez, B., Aparicio‐Bautista, D. I., Argoty-Pantoja, A. D., Patiño, N., Flores-Morales, J., Salmerón, J., León‐Reyes, G., & Velázquez‐Cruz, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911815 · Cited by 10
Богачевская, С. А., & Николаевич, Б. А. (2017) · Social Aspects of Population Health · doi:10.21045/2071-5021-2017-53-1-1 · Cited by 10
Zhu, W., Liang, L., Wang, C. L., & Fu, J. F. (2013) · Indian Pediatrics · doi:10.1007/s13312-013-0121-1 · Cited by 7
Impacto de la apolipoproteína A5 en el riesgo cardiovascular: Modulaciones genéticas y ambientales
Sotos‐Prieto, M., Francès, F., & Corella, D. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010000700013 · Cited by 9
shinyuna, 유현승, 임강일, Kim, J.-T., & Suk, M. (2010) · 한국특수체육학회지 · doi:10.17006/kjapa.2010.18.3.111 · Cited by 7
LDL resistance to oxidation: Effects of lipid phenotype, autologous HDL and alanine
Baldi, S., Frascerra, S., Ferrannini, E., & Natali, A. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.12.019 · Cited by 6
Dall, T., & Bays, H. E. (2009) · Southern Medical Journal · doi:10.1097/smj.0b013e31819b08f7 · Cited by 4
Modeling, analysis and optimization of calibration uncertainty in clinical laboratories
Ramamohan, V., Abbott, J. T., Klee, G. G., & Yih, Y. (2014) · Measurement · doi:10.1016/j.measurement.2013.12.027 · Cited by 5
Premature Onset of Cardiovascular Disease in HIV-Infected Individuals: The Drugs and the Virus
Maisa, A., Westhorpe, C. L. V., Elliott, J., Jaworowski, A., Hearps, A. C., Dart, A. M., Hoy, J., & Crowe, S. M. (2010) · HIV Therapy · doi:10.2217/hiv.10.53 · Cited by 4
Effects of cigarette smoking on serum lipids among priests in Bangkok.
Saengdith, P. (2008) · PubMed · Cited by 4
The association between rapid growth and lipid profile: a systematic review and meta-analysis
Chen, B., Chen, Y., Wang, Y., Xin, Q., & Ma, D. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1353334 · Cited by 3
Bouillet, B., Boulestreau, R., Aboyans, V., Béliard, S., Boccara, F., Cariou, B., Charrière, S., Moulin, P., Vergès, B. L., Valéro, R., et al. (2026) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2026.01.001 · Cited by 2
Blau, L. S., Gerber, J., Finkel, A., Lützow, M., Maassen, N., Röhrich, M. A., Hanff, E., Tsikas, D., Shushakov, V., & Jantz, M. (2023) · Applied Sciences · doi:10.3390/app13116849 · Cited by 2
Hu, X., Xu, J., & Gu, Y. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1433884 · Cited by 2
Triglicéridos en ayunas y posprandiales, y su contribución al estudio del riesgo cardiometabólico
Rodulfo, J. I. A., Ponte-Negretti, C. I., & Candia, F. A. (2009) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(09)72959-6 · Cited by 7
Ácidos grasos omega-3 y prevención cardiovascular
Travieso, J. C. F. (2010) · Revista CENIC. Ciencias biológicas · Cited by 3
Evaluation and Treatment of Atherogenic Dyslipidemia
González-Campoy, J. M., & Houston, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_12 · Cited by 1
Vergès, B. L. (2013) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(13)51263-7 · Cited by 2
Perspectiva genética del tratamiento nutricional en la enfermedad cardiovascular
Martín, A. Á. (2013) · Dialnet (Universidad de la Rioja)
Mortality and morbidity in patients with Addison's disease
Bergthorsdottir, R. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
The involvement of INSIGs, DGAT1 and APOB in human lipid metabolism
Krapivner, S. (2008) · Figshare
The Effects of Senior Dance and Elastic Band Exercise on Blood Lipids and BDNF in Elderly Women
김순경 (2011) · The Journal of Korean Dance · doi:10.15726/jkd.2011.29.1.012
Atherosclerosis: Basic Principles and Medical Management
O’Connell, J. B., & Bath, J. (2011) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814317788_0001
Hypolipidemic drugs and their effect on endothelial function: a review of results of clinical trials
Dobiaš, L., Laššánová, M., & Kristová, V. (2016) · Klinická farmakologie a farmacie · doi:10.36290/far.2016.018
Very Severe Hypertriglyceridemia-Casre Report with General Considerations
Miulescu, R. D., Tinu, A. M., Margina, D. M., Grădinaru, D., Ungurianu, A., & Guja, L. (2018) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2018-0051
Xhardo, E., & Agaçi, F. (2020) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.16.2.2020.201304
Chigbo, D. C. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.19.3.1988 · Cited by 3
Panorama general del riesgo cardiovascular residual
Aristizábal-Colorado, D., Quintero-Zea, K., & Sierra-Castillo, S. (2024) · Interdisciplinary Journal of Epidemiology and Public Health · doi:10.18041/2665-427x/ijeph.1.10357
Bouillet, B., Boulestreau, R., Aboyans, V., Béliard, S., Boccara, F., Cariou, B., Charrière, S., Moulin, P., Vergès, B. L., Valéro, R., et al. (2025) · Annales d Endocrinologie · doi:10.1016/j.ando.2025.102471
Vergès, B. L. (2026) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(24)48948-8
Chin, A. L., & O’Connell, J. B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-28432-8.00012-0
Metadata
- Authors
- Abdel-Maksoud, M. F., & Hokanson, J. E.
- Affiliations
- University of Colorado Denver (US)
- ORCID
- Hokanson, John E.
- Venue
- Seminars in Vascular Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 2002
- Volume
- 02
- Issue
- 3
- Pages
- 325-334
- ISSN
- 1528-9648 (ISSN-L)
- 1529-3505
- OpenAlex
- W1981903279
- Cited by
- 76
- References
- 0
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 1 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 6 · 2012: 6
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Vascular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- triglycerides, cardiovascular disease, HDL cholesterol, cardiovascular risk factors, relative risk, prospective cohort
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.